Abstract:
A magnetic conductive recipient comprising: magnetic field via magnetized water. This process provides means for drug delivery in a molecular state, control of blood circulation, control of internal and/or external cell organism functions, including MWRI (magnetic water resonance imaging).

Description:
BACKGROUND 
       [0001]    In the ongoing effort to better control administered drugs to a patient and following the process to reach the desired outcome during and after administration. Much as been aimed at controlling the quantities that are administered. Some examples of this are: Zero-order drug delivery using infusion pumps, time release drug patches, or the use of polymers such as described with U.S. Pat. No. 7,187,969 B2 entitled “ELECTROACTIVE PORE” and included here as reference. However there as been less attempt at controlling the drugs once administered. Some exceptions to this, such as time release capsules, have some control after administration, in relation to time and quantity. However this does not address control over the drugs orientation once they have been administered, which leaves a blind spot as to the extent of their effectiveness. One example of this; is blood circulation, and the outcome this may have on the drugs distribution, where both benefits and repercussions may occur. For example: when the initial target was a specific organ or cell(s), however neighboring organs, or cells are effected and/or contaminated by the administered drugs, brought on by the process of blood circulation. With the present embodiment, a patient is placed into a magnetic conductive recipient containing magnetized water that is in contact with the patient&#39;s skin wherein, drugs distribution and speed at which the drugs are distributed throughout the body, are both controlled after the drugs are administered, via: the magnetized water, that provides control over blood circulation. Furthermore theses processes may be monitored via MWRI (magnetized water resonance imaging), using drug dye, and will become more apparent in the summary, and claims. 
       SUMMARY 
       [0002]    A method, and apparatus, wherein any organism(s) including: a human(s), or animal(s), or cell(s), plant(s), DNA, RNA, clone organism(s), organic organism(s) and/or transgenic organism(s) is placed within a magnetic conductive recipient containing magnetized water. And in this process, creating a powerful new tool, having magnetic field control, over the magnetized water, via the magnetic conductive recipient. For example: wherein a human having been administered therapeutic agents: Control is achieved of the administered drugs distribution throughout the body, by controlling the blood circulation throughout the body, that is composed mainly of water, as described in (The effect of water drinking on the blood composition of human subjects in relation to diuresis), F. H. Smirk J. Physiol. VOL 78(2): 127-146) May 23, 1933 London ENGLAND; and included here as reference. 
         [0003]    Herein the magnetic field is extended via the patient&#39;s blood, and controlled via the magnetic conductive recipient. Other benefits include: molecular drug delivery, blood filtering, control of blood flow, free radical extraction, pain control, reducing inflammation, to name some. Magnetic field via magnetized water can perform deep penetrating, and absorption process, via blood circulation. Furthermore providing MWRI (magnetized water resonance imaging), which distinguishes it from conventional MRI (magnetic resonance imaging) methods; where MWRI can reach at angles that is unheard of with conventional MRI methods. Taken a human body for instance. Magnetized water surrounds the body, and molds to every possible angle, by being in direct contact with the patients skin. Where conventional MRI as very limited control to reach angles in comparison. The consequence is distortion, a well known to the art fact, that is not adequately solved, whether it be MRI using coil, or open room MRI, both well known to the art. 
         [0004]    Other methods and materials for drug delivery that may be used, in single, or in combination via the magnetic conductive recipient, are for example: pulsation, water agitation, to name some. Further uses with, MWRI comprises: SQUID (superconducting quantum interference device); that enable&#39;s magnetic fields operating conditions below 1 Telsa. 
         [0005]    Further characteristics and advantages will become apparent from the detailed description, illustrated by non-limitative example. 
     
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         [0006]      FIG. 1  is a block diagram showing an ensemble of a system having a magnetic conductive recipient apparatus according to one embodiment of the present invention. 
           [0007]      FIG. 2  is a diagram showing a detailed example of the structure of a magnetic conductive recipient apparatus to  FIG. 1 . 
           [0008]      FIG. 3  is an exploded cross-sectional view of a cell magnetic conductive recipient unit according to another embodiment of the present invention. 
           [0009]      FIG. 4  shows an above view of the magnetic conductive recipient for cells to  FIG. 3 , without the cover. 
           [0010]      FIG. 5  shows an above view of the magnetic conductive recipient cover for cells to  FIG. 3 . 
       
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
       [0011]    The present invention is described with reference to the drawings. 
         [0012]      FIG. 1 , is a block diagram showing an ensemble of a system via several units, wherein a magnetic conductive recipient apparatus for humans  18  is the center thereof. The magnetic conductive recipient  18  emits a magnetic field used for therapeutic treatments via methods, and means that comprises: software(s)  10 , installed on a computer  12  having a computer monitor  11 , are in turn connected to a control sequence transmitter receiver unit  15 ; that control a power supply  13 , where electric current is controlled via a current regulator  14  before reaching the magnetic conductive recipient  18 . This activates the magnetic field inside the magnetic conductive recipient  18 ; and in the process magnetizing the water  18   b  contained in the magnetic conductive recipient  18 , shown surrounding a human organism  19 . Means are provided for drug delivery (in a molecular state), via: the extraction process  17 , wherein 
         [0000]    Molecules deriving from substances  16  are extracted and transferred via the magnetic conductive recipient(s)  18 . The extraction process  17  may take many forms, that comprises: steam distillation, cloud point extraction, supercritical carbon dioxide extraction to name some methods. 
         [0013]      FIG. 2 , shows the structural composition of a magnetic conductive recipient according to the present embodiment, wherein the exterior layer is a magnetic barrier layer  20 , preventing exterior frequencies, exterior currents, and exterior magnetic fields, from penetrating, or interfering with the prescribed functions of the present embodiment. Shown in  FIG. 2 , is a container layer  21 , wherein comprises carbon dioxide gas coolant, serving as a means for maintaining an adequate temperature within the magnetic conductive recipient structure  FIG. 2 , wherein tubing  24  serves to circulate carbon dioxide coolant from the container layer  21 , throughout the structure of the magnetic conductive recipient. Super conductive wire  23 , serves as transport means for drug delivery (in a molecular state) deriving from the extraction process  17  ( FIG. 1 ), via the magnetic conductive materials layer  25 ; in turn via the magnetized water  18   b  ( FIG. 1 ), and magnetized water  33  ( FIG. 4 ) before reaching an organism in contact with the magnetized water, according to embodiments of the present invention. The magnetic conductive materials layer  25  is activated and controlled via circuit board panel(s) of layer  22 . in turn these components control the magnetized water  18   b  ( FIG. 1 ), and the magnetized water  33  as shown in ( FIG. 4 ). 
         [0014]      FIG. 3 , shows a magnetic conductive recipient for cells  31 , having support columns  28 , that rest upon leveling mounts  27 . A central cavity  32 , containing magnetized water  33  as shown in ( FIG. 4 ); herein the cells are placed. Furthermore the magnetic conductive recipient for cells  31 , as a magnetic conductive recipient cover for cells  30 , wherein conductive contact is made between  30  and  31 , when  30  is placed onto  31 . All other conductive connections that comprises: electrical power, sequence commands, drug delivery (in a molecular state) deriving from super conductive wire  23  ( FIG. 2 ), via the extraction process  17  ( FIG. 1 ); all connect via: port  29 . Two multiple purpose tubes  26 , traverse through the above exterior, of the magnetic conductive recipient cover for cells  30 , into the central cavity  32 , immediately above  32 . Multiple purpose tubes  26  serve as means for introducing cells, as an entry for surgical tools, needles, and water replenishing means for central cavity  32 , and as overflow means of central cavity  32 , to name some. 
         [0015]      FIG. 4 , shows the magnetic conductive recipient for cells  31  ( FIG. 3 ), and the central cavity  32  ( FIG. 3 ) viewed from above, where a cell organism  34 , is in direct contact with magnetized water  33 . When the magnetic conductive cover for cells  30  ( FIG. 3 ) (not shown) in  FIG. 4 , is joined with the magnetic conductive recipient for cells  31  ( FIG. 3 ), as shown and described to claim  3 ; and is activated via means described to ( FIG. 1 ). Multiple directional control is achieved, simultaneously (in every direction), as illustrated in  FIG. 4 , by: N=North, S=South, W=West, E=East. In turn spreading the process as described to claim  4 , via the magnetized water  33 , internally and externally controlling the cell organism  34 , within the central cavity  32 . Herein the described processes to  FIG. 4  are in accordance to inverse square law 
         [0000]    
       
         
           
             
               ( 
               
                 
                   S 
                   
                     4 
                      
                     π 
                      
                     
                         
                     
                      
                     
                       r 
                       2 
                     
                   
                 
                 = 
                 1 
               
               ) 
             
             . 
           
         
       
     
         [0016]    More on the methods to  FIG. 4 , are to be found in the claims of the present embodiment. 
         [0017]      FIG. 5 , shows an above view of the magnetic conductive recipient cover for cells  30  ( FIG. 3 ), with an interior view of the multipurpose tubes  26  ( FIG. 3 ). Further shows the insertion holes  35 , within the multipurpose tubes  26  ( FIG. 3 ). 
         [0018]    Although particular embodiments of the invention herein have been described, it is not limited to this description. It is therefore to be understood that numerous modifications may be made to the embodiments without departing from the spirit and scope of the present invention. Other embodiments are to be found in the claims.